Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer

Xiyone Liu, Bingsen Zhou, Lijun Xue, Frank Yen, Peiguo Chu, Frank Un, Yun Yen

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Background: Ribonucleoside diphosphate reductase plays a key role in converting ribonucleoside diphosphate to 2′-deoxyribonucleoside diphosphate, which is necessary for DNA repair and replication. To determine if human ribonucleotide reductase small subunit M2 (hRRM2) and p53-dependent human ribonucleotide reductase small subunit R2 (p53R2) play roles on invasion ability of cancer cells, the gene transferring technique was used to construct stable hRRM2 and p53R2 overexpression transfectants. Increase of hRRM2 dramatically enhanced the cell migration in KB and PC-3 cells, but p53R2 overexpression reduced cellular invasion potential to 50% and 40% in KB and PC-3 cells, respectively. Furthermore, hRRM2 enhanced cancer cells to induce the cell migration of Human Umbilical Vein Endothelial Cells, but p53R2 reduced this ability in transfectants. Patients and Methods: To further determine the role of human ribonucleotide reductase subunits on cancer metastasis, a tissue array, including 59 primary and 49 metastatic colon adenocarcinoma samples, was used. Immunohistochemistry was used to evaluate the relationship between human ribonucleotide reductase subunits and metastasis. Results: Univariate and multivariate analysis revealed that p53R2 is negatively related to the metastasis of colon adenocarcinoma samples (odds ratio, 0.23; P < 0.05); hRRM2 increases the risk of metastasis in colon cancer, but did not show significantly. Thus, opposing regulation of hRRM2 and p53R2 in invasion potential might play a critical role in determining the invasion and metastasis phenotype in cancer cells. Conclusion: The expression level of ribonucleotide reductase small subunits could serve as biomarkers to predict the malignancy potential of human cancers in the future.

Original languageEnglish
Pages (from-to)374-381
Number of pages8
JournalClinical Colorectal Cancer
Volume6
Issue number5
DOIs
Publication statusPublished - Jan 1 2007
Externally publishedYes

Fingerprint

Colonic Neoplasms
Biomarkers
Neoplasm Metastasis
Ribonucleotide Reductases
Diphosphates
Neoplasms
Cell Movement
Ribonucleoside Diphosphate Reductase
Colon
Adenocarcinoma
ribonucleotide reductase M2
Deoxyribonucleosides
Ribonucleosides
Neoplasm Genes
Human Umbilical Vein Endothelial Cells
DNA Replication
DNA Repair
Multivariate Analysis
Immunohistochemistry
Odds Ratio

Keywords

  • Cell migration
  • Gene transfection
  • Immunohistochemistry
  • Relative risk
  • Short interference RNA

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer. / Liu, Xiyone; Zhou, Bingsen; Xue, Lijun; Yen, Frank; Chu, Peiguo; Un, Frank; Yen, Yun.

In: Clinical Colorectal Cancer, Vol. 6, No. 5, 01.01.2007, p. 374-381.

Research output: Contribution to journalArticle

Liu, Xiyone ; Zhou, Bingsen ; Xue, Lijun ; Yen, Frank ; Chu, Peiguo ; Un, Frank ; Yen, Yun. / Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer. In: Clinical Colorectal Cancer. 2007 ; Vol. 6, No. 5. pp. 374-381.
@article{00884d3f7a9e452b8a1218e188f6f20e,
title = "Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer",
abstract = "Background: Ribonucleoside diphosphate reductase plays a key role in converting ribonucleoside diphosphate to 2′-deoxyribonucleoside diphosphate, which is necessary for DNA repair and replication. To determine if human ribonucleotide reductase small subunit M2 (hRRM2) and p53-dependent human ribonucleotide reductase small subunit R2 (p53R2) play roles on invasion ability of cancer cells, the gene transferring technique was used to construct stable hRRM2 and p53R2 overexpression transfectants. Increase of hRRM2 dramatically enhanced the cell migration in KB and PC-3 cells, but p53R2 overexpression reduced cellular invasion potential to 50{\%} and 40{\%} in KB and PC-3 cells, respectively. Furthermore, hRRM2 enhanced cancer cells to induce the cell migration of Human Umbilical Vein Endothelial Cells, but p53R2 reduced this ability in transfectants. Patients and Methods: To further determine the role of human ribonucleotide reductase subunits on cancer metastasis, a tissue array, including 59 primary and 49 metastatic colon adenocarcinoma samples, was used. Immunohistochemistry was used to evaluate the relationship between human ribonucleotide reductase subunits and metastasis. Results: Univariate and multivariate analysis revealed that p53R2 is negatively related to the metastasis of colon adenocarcinoma samples (odds ratio, 0.23; P < 0.05); hRRM2 increases the risk of metastasis in colon cancer, but did not show significantly. Thus, opposing regulation of hRRM2 and p53R2 in invasion potential might play a critical role in determining the invasion and metastasis phenotype in cancer cells. Conclusion: The expression level of ribonucleotide reductase small subunits could serve as biomarkers to predict the malignancy potential of human cancers in the future.",
keywords = "Cell migration, Gene transfection, Immunohistochemistry, Relative risk, Short interference RNA",
author = "Xiyone Liu and Bingsen Zhou and Lijun Xue and Frank Yen and Peiguo Chu and Frank Un and Yun Yen",
year = "2007",
month = "1",
day = "1",
doi = "10.3816/CCC.2007.n.007",
language = "English",
volume = "6",
pages = "374--381",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer

AU - Liu, Xiyone

AU - Zhou, Bingsen

AU - Xue, Lijun

AU - Yen, Frank

AU - Chu, Peiguo

AU - Un, Frank

AU - Yen, Yun

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Background: Ribonucleoside diphosphate reductase plays a key role in converting ribonucleoside diphosphate to 2′-deoxyribonucleoside diphosphate, which is necessary for DNA repair and replication. To determine if human ribonucleotide reductase small subunit M2 (hRRM2) and p53-dependent human ribonucleotide reductase small subunit R2 (p53R2) play roles on invasion ability of cancer cells, the gene transferring technique was used to construct stable hRRM2 and p53R2 overexpression transfectants. Increase of hRRM2 dramatically enhanced the cell migration in KB and PC-3 cells, but p53R2 overexpression reduced cellular invasion potential to 50% and 40% in KB and PC-3 cells, respectively. Furthermore, hRRM2 enhanced cancer cells to induce the cell migration of Human Umbilical Vein Endothelial Cells, but p53R2 reduced this ability in transfectants. Patients and Methods: To further determine the role of human ribonucleotide reductase subunits on cancer metastasis, a tissue array, including 59 primary and 49 metastatic colon adenocarcinoma samples, was used. Immunohistochemistry was used to evaluate the relationship between human ribonucleotide reductase subunits and metastasis. Results: Univariate and multivariate analysis revealed that p53R2 is negatively related to the metastasis of colon adenocarcinoma samples (odds ratio, 0.23; P < 0.05); hRRM2 increases the risk of metastasis in colon cancer, but did not show significantly. Thus, opposing regulation of hRRM2 and p53R2 in invasion potential might play a critical role in determining the invasion and metastasis phenotype in cancer cells. Conclusion: The expression level of ribonucleotide reductase small subunits could serve as biomarkers to predict the malignancy potential of human cancers in the future.

AB - Background: Ribonucleoside diphosphate reductase plays a key role in converting ribonucleoside diphosphate to 2′-deoxyribonucleoside diphosphate, which is necessary for DNA repair and replication. To determine if human ribonucleotide reductase small subunit M2 (hRRM2) and p53-dependent human ribonucleotide reductase small subunit R2 (p53R2) play roles on invasion ability of cancer cells, the gene transferring technique was used to construct stable hRRM2 and p53R2 overexpression transfectants. Increase of hRRM2 dramatically enhanced the cell migration in KB and PC-3 cells, but p53R2 overexpression reduced cellular invasion potential to 50% and 40% in KB and PC-3 cells, respectively. Furthermore, hRRM2 enhanced cancer cells to induce the cell migration of Human Umbilical Vein Endothelial Cells, but p53R2 reduced this ability in transfectants. Patients and Methods: To further determine the role of human ribonucleotide reductase subunits on cancer metastasis, a tissue array, including 59 primary and 49 metastatic colon adenocarcinoma samples, was used. Immunohistochemistry was used to evaluate the relationship between human ribonucleotide reductase subunits and metastasis. Results: Univariate and multivariate analysis revealed that p53R2 is negatively related to the metastasis of colon adenocarcinoma samples (odds ratio, 0.23; P < 0.05); hRRM2 increases the risk of metastasis in colon cancer, but did not show significantly. Thus, opposing regulation of hRRM2 and p53R2 in invasion potential might play a critical role in determining the invasion and metastasis phenotype in cancer cells. Conclusion: The expression level of ribonucleotide reductase small subunits could serve as biomarkers to predict the malignancy potential of human cancers in the future.

KW - Cell migration

KW - Gene transfection

KW - Immunohistochemistry

KW - Relative risk

KW - Short interference RNA

UR - http://www.scopus.com/inward/record.url?scp=33847417505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847417505&partnerID=8YFLogxK

U2 - 10.3816/CCC.2007.n.007

DO - 10.3816/CCC.2007.n.007

M3 - Article

C2 - 17311703

AN - SCOPUS:33847417505

VL - 6

SP - 374

EP - 381

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 5

ER -